A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)
NCT06592339
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
MK-0616
Sponsor
Merck Sharp & Dohme LLC